The US Food & Drug Administration has given nod to a new flu vaccine known as ‘Afluria.’ Austrian researchers have designed the new drug in order to defend grown-ups from influenza A and B viruses.

The Afluria vaccine is made from deactivated flu viruses developed in chicken eggs. Individuals allergic to eggs or any other constituent of the vaccine should not take it.

The most common fallouts linked to the vaccine include soreness, redness, tenderness and puffiness at the injection site, headaches, weakness and muscle aches.

Children between 6 months to 5 years of age, expecting women, people aged between 50 years and older, people of any age with sure chronic medical conditions, and those who live in nursing homes and other long-term care facilities, should be given Alfuria in flu period.

Around 2 million dosages of the vaccine will be supplied to the United States market in the recent year (2007).